SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2010 / Cilt: 16 - Sayı: 3

Olumsuz servikse sahip nullipar term gebelerin doğum indüksiyonunda iki yöntemin karşılaştırılması: Sadece oksitosin kullanımı yada dinoproston vaginal yavaş salınım sistemi (Propess®)+Oksitosin

Comparison of two methods in labor induction in nulliparous women with unfavorable cervix at term: Oxytocin alone versus dinoprostone vaginal slow-release system (Propess®) + Oxytocin

M.Tunç CANDA
Namık DEMİR
Orçun SEZER
Pages
141–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSI ONS: The use of dinoproston e vaginal slow-release system plus oxytocin for labor induction in nulliparous women with unfavorable cervix at term seems to be more effective than oxytocin alone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE S: To investigate the efficacy of two labor induction protocols.
📊
Key Findings & Data:STUDY DESIGN: In this retrospectiv e study, pregnancy records of 50 nulliparous singletons at term with intact membranes and Bishop score ≤ 6, delivered vaginally with one of the two induction methods were reviewed.
💡
Conclusion & Impact:CONCLUSI ONS: The use of dinoproston e vaginal slow-release system plus oxytocin for labor induction in nulliparous women with unfavorable cervix at term seems to be more effective than oxytocin alone.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE S: To investigate the efficacy of two labor induction protocols. STUDY DESIGN: In this retrospectiv e study, pregnancy records of 50 nulliparous singletons at term with intact membranes and Bishop score &#8804; 6, delivered vaginally with one of the two induction methods were reviewed. Subjects were divided into 2 groups. Group 1; labor induction with oxytocin alone (n=20), Group 2; labor induction with dinoproston e + oxytocin (n=30). RESULTS: Maternal age, time of amniotomy, labor induction to active labor interval, birth weights, pre and postlabor hemoglobin levels and uterine hyperactivity did not show any statistical difference between groups. Oxytocin use was significantly lower and labor induction to delivery interval was found statistically shorter in group 2 (p< 0.05). CONCLUSI ONS: The use of dinoproston e vaginal slow-release system plus oxytocin for labor induction in nulliparous women with unfavorable cervix at term seems to be more effective than oxytocin alone.

Özet

AMAÇ: İki doğum indüksiyonu protokolünün etkinliğinin araştırılması. GEREÇ VE YÖNTEM: Bu retrospektif çalışmada, iki doğum indüksiyon yönteminden biri ile vaginal doğum yapan, nullipar, tekiz, term, membranları intakt, Bishop skoru ≤ 6 olan 50 gebenin kayıtları gözden geçirildi. BULGULAR: İki grup arasında, anne yaşı, amniotomi zamanı, aktif travaya giriş zamanı, doğum ağrılıkları, doğum öncesi ve sonrası hemoglobin düzeyleri ve aşırı uterus aktivitesi yönünden istatistiksel fark saptanmadı. Grup 2’de kullanılan oksitosin anlamlı olarak daha az ve doğum süresi anlamlı olarak daha kısa idi (p< 0.05). SONUÇ: Olumsuz servikse sahip nullipar term gebelerin travay indüksiyonunda dinoproston vaginal yavaş salınım sistemi ile birlikte oksitosin kullanımı tek başına oksitosin kullanımına göre daha etkin görünmektedir.

🔖

Cite This Article

CANDA, M., DEMİR, N., SEZER, O. (2010). Olumsuz servikse sahip nullipar term gebelerin doğum indüksiyonunda iki yöntemin karşılaştırılması: Sadece oksitosin kullanımı yada dinoproston vaginal yavaş salınım sistemi (Propess®)+Oksitosin. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 16 - Sayı: 3, 141–143. https://ajindex.com/articles/227046

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2006. Natl Vital Stat Rep 2009;57:1-102
  2. Ben-Haroush A, Yogev Y, Bar J, Glickman H, Kaplan B, Hod M. Indicated labor induction with vaginal prostoglandin E2 increases the risk of cesarean section even in multiparous women with no previous cesarean section. J Perinat Med. 2004;32:31-6
  3. Witter FR, Mercer BM. Improved intravaginal controlledrelease prostaglandin E2 insert for cervical ripening at term: the prostaglandin E2 insert study group. J Matern Fetal Med 1996;5:64-9
  4. Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labor. Cochrane Database Syst Rev.2009;7:CD003246
  5. Kalkat RK, McMillan E, Cooper H, Palmer K. Compa - rison of Dinoprostone slow release pessary (Propess) with gel (Prostin) for induction of labour at term-a randomised trial. J Obstet Gynaecol. 2008;28:695-9
  6. ACOG technical bulletin. Induction of labor. Number 217-Dec 1995 American college of Obstetricians Gynecologists. Int J Gynaecol Obstet. 1996;53(1):65-72
  7. Tan PC, Jacob R, Omar SZ. Membrane sweeping at initiation of labor induction: a randomized controlled trial. Obstet Gynecol. 2006;107:569-77
  8. Kelly AJ, Malik S, Smith L, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labor at term. Cochrane Database Syst Rev.2009;7: CD003101
  9. WielgosM, Szymusik I, Kosinska-Kaczynska K, et al. The influence of dinoprostone on cervical ripening and the course of labor. Neuro Endocrinol Lett. 2007;28:513-7
  10. Tan PC, Valiapan SD, Tay PY, Omar SZ. Concurrent oxyto cin with dinoprost pessary versus dinoprost pessary in labour induction with an unfavourable cervix: a randomized placebo-controlled trial. BJOG. 2007;114:824-32
  11. Tan PC, Daud SA, Omar SZ. Concurrent dinoprostone and oxytocin for labor induction in term premature rupture of membranes: a randomized controlled trial. Obstet Gyne - col. 2009;113:1059-65
  12. Kunt C, Kanat-Pektas M, Gungor AN, et al. Randomized trial of vaginal prostaglandin E2 versus oxytocin for labor induction in term premature rupture of membranes. 2010; 49:57-61
  13. Larranaga-Azcarate C, Campo-Molina G, Perez-Rodrigez AF, Ezcurdia-Gurpegui M. Dinoprostone vaginal slow-release system (Propess®) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes. Acta Obstet Gynecol Scand. 2008;87:195-200.